Figure 3.
Postrelapse OS of patients receiving BuCy (solid red line) or BuFlu (dashed blue line). (A) Patients with malignancies. (B) Patients with AML in complete remission.

Postrelapse OS of patients receiving BuCy (solid red line) or BuFlu (dashed blue line). (A) Patients with malignancies. (B) Patients with AML in complete remission.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal